ETF Holdings Breakdown of AXGN

Stock Name	Axogen Inc
Ticker	AXGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05463X1063

AXGN institutional holdings

The following institutional investment holdings of AXGN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-17 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 6,741 USD 111,833

2025-10-17 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 54,509 USD 904,304

2025-10-17 IE00BMX0DF60 (iShares US Medical Devices UCITS ETF) 6,100 USD 101,199

2025-10-17 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 28,898 USD 479,418

Total = 96,248 USD 1,596,754
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	6,741	USD 111,833
2025-10-17	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	54,509	USD 904,304
2025-10-17	IE00BMX0DF60 (iShares US Medical Devices UCITS ETF)	6,100	USD 101,199
2025-10-17	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	28,898	USD 479,418
Total =	96,248	USD 1,596,754

News associated with AXGN

AxoGen, Inc. (NASDAQ:AXGN) Short Interest Update: AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 4,100,000 shares, anincreaseof32.7% from the July 15th total of 3,090,000 shares. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is presently 3.7 days. […] - 2025-08-22 04:54:51
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Deutsche Bank AG: Deutsche Bank AG lessened its position in AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 0.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 591,319 shares of the medical equipment provider’s stock after selling 3,524 shares during the period. Deutsche Bank […] - 2025-08-15 05:22:53
Analyzing AxoGen (NASDAQ:AXGN) and Waters (NYSE:WAT): AxoGen (NASDAQ:AXGN – Get Free Report) and Waters (NYSE:WAT – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations. Volatility and Risk AxoGen has a beta of 1, suggesting […] - 2025-08-15 02:11:00
Wall Street Zen Upgrades AxoGen (NASDAQ:AXGN) to Buy: AxoGen (NASDAQ:AXGN – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. Separately, Canaccord Genuity Group dropped their price objective on AxoGen from $26.00 to $24.00 and set a “buy” rating on the stock in a research […] - 2025-08-11 03:58:52
Exchange Traded Concepts LLC Sells 13,083 Shares of AxoGen, Inc. (NASDAQ:AXGN): Exchange Traded Concepts LLC trimmed its stake in AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 20.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 51,235 shares of the medical equipment provider’s stock after selling 13,083 shares during the period. Exchange […] - 2025-06-20 05:16:57
Nuveen Asset Management LLC Reduces Stake in AxoGen, Inc. (NASDAQ:AXGN): Nuveen Asset Management LLC lessened its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 14.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 127,076 shares of the medical equipment provider’s stock after selling 21,370 shares during the period. Nuveen Asset Management LLC’s holdings in AxoGen were worth $2,094,000 as of […] - 2025-06-03 04:50:50
AxoGen, Inc. (NASDAQ:AXGN) Receives $22.20 Average Price Target from Analysts: Shares of AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) have been assigned a consensus recommendation of “Buy” from the five research firms that are covering the firm, Marketbeat reports. Five analysts have rated the stock with a buy recommendation. The average 1 year price target among brokerages that have issued a report on the stock […] - 2025-06-03 02:51:03
AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Squarepoint Ops LLC: Squarepoint Ops LLC lifted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 86.7% during the fourth quarter, Holdings Channel reports. The fund owned 55,668 shares of the medical equipment provider’s stock after purchasing an additional 25,853 shares during the quarter. Squarepoint Ops LLC’s holdings in AxoGen were worth $917,000 at the […] - 2025-06-02 06:24:53
State of Wyoming Invests $31,000 in AxoGen, Inc. (NASDAQ:AXGN): State of Wyoming purchased a new position in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 1,857 shares of the medical equipment provider’s stock, valued at approximately $31,000. A number of other hedge funds have also made changes to their positions in AXGN. SG […] - 2025-05-30 05:12:52
Bank of America Corp DE Sells 86,614 Shares of AxoGen, Inc. (NASDAQ:AXGN): Bank of America Corp DE reduced its stake in AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 17.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 402,523 shares of the medical equipment provider’s stock after selling 86,614 shares during the period. Bank of America […] - 2025-05-27 04:42:56
12,867 Shares in AxoGen, Inc. (NASDAQ:AXGN) Acquired by Graham Capital Management L.P.: Graham Capital Management L.P. acquired a new position in AxoGen, Inc. (NASDAQ:AXGN – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,867 shares of the medical equipment provider’s stock, valued at approximately $212,000. A number of other hedge funds also recently […] - 2025-05-19 05:28:48
AxoGen (NASDAQ:AXGN) Price Target Lowered to $24.00 at Canaccord Genuity Group: AxoGen (NASDAQ:AXGN – Free Report) had its price target decreased by Canaccord Genuity Group from $26.00 to $24.00 in a research note released on Tuesday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical equipment provider’s stock. A number of other equities research analysts have also recently weighed in on the […] - 2025-05-14 05:36:46
Invesco Ltd. Has $283,000 Position in AxoGen, Inc. (NASDAQ:AXGN): Invesco Ltd. cut its stake in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 93.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,192 shares of the medical equipment provider’s stock after selling 260,294 shares during the quarter. Invesco Ltd.’s holdings in AxoGen […] - 2025-05-05 05:14:59
AxoGen, Inc. (NASDAQ:AXGN) Receives $22.60 Average Price Target from Analysts: Shares of AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) have earned a consensus rating of “Buy” from the five analysts that are presently covering the firm, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have issued a report on the stock in the […] - 2025-04-14 02:46:45
AxoGen, Inc. (NASDAQ:AXGN) Holdings Boosted by Arrowstreet Capital Limited Partnership: Arrowstreet Capital Limited Partnership grew its holdings in AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 37.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 97,290 shares of the medical equipment provider’s stock after purchasing an additional 26,298 shares during the period. […] - 2025-04-11 06:09:09
Corebridge Financial Inc. Trims Stake in AxoGen, Inc. (NASDAQ:AXGN): Corebridge Financial Inc. lessened its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 7.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 21,081 shares of the medical equipment provider’s stock after selling 1,591 shares during the period. Corebridge Financial Inc.’s holdings in AxoGen were worth $347,000 at the end of the […] - 2025-04-10 04:50:45
Prudential Financial Inc. Has $6.89 Million Stake in AxoGen, Inc. (NASDAQ:AXGN): Prudential Financial Inc. reduced its position in AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 3.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 418,285 shares of the medical equipment provider’s stock after selling 15,700 shares during the quarter. Prudential Financial […] - 2025-03-31 05:22:46
AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Intech Investment Management LLC: Intech Investment Management LLC increased its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 33.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,456 shares of the medical equipment provider’s stock after purchasing an additional 4,141 shares […] - 2025-03-27 06:22:57
AxoGen (NASDAQ:AXGN) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says: AxoGen (NASDAQ:AXGN – Get Free Report) had its target price hoisted by Canaccord Genuity Group from $22.00 to $26.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s target price indicates a potential upside of 33.81% from the company’s previous close. […] - 2025-02-28 04:52:44
AxoGen (NASDAQ:AXGN) Given New $22.00 Price Target at Canaccord Genuity Group: AxoGen (NASDAQ:AXGN – Get Free Report) had its price objective increased by investment analysts at Canaccord Genuity Group from $18.00 to $22.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s target price indicates a potential upside of 21.68% from […] - 2025-02-05 04:28:49
R Squared Ltd Takes Position in AxoGen, Inc. (NASDAQ:AXGN): R Squared Ltd acquired a new position in AxoGen, Inc. (NASDAQ:AXGN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,815 shares of the medical equipment provider’s stock, valued at approximately $30,000. Several other hedge funds also recently added to or […] - 2025-02-04 07:19:46

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.